Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Why Viking Therapeutics Stock Skyrocketed on Tuesday

The biotech's obesity drug candidate could make it easier for people who have recently lost weight to keep it off.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

More from Wednesday 23 September →